Fox Factory reported Q1 earnings and had their conference call moments ago. Here’s the fast breakdown:
Important metrics
- Net Revenue: $355M vs consensus of $324M
- Adjusted EPS: $0.23 vs consensus of $0.22
- Adjusted EBITDA $39.6M; down 2% year over year (y/y)
- Guidance for the year reaffirmed. (this is good)
- Stock is trading up ~9% in post market trading on top of the ~5% it traded up leading into the earnings report (overall its up about 14% on the day, market liked the results).
Tariffs: The Elephant in the Room
Management didn’t dodge it tariffs are a $50M annual headwind (~5% of COGS). That’s baked into the forecast, but they were clear: if consumer demand weakens or macro conditions deteriorate, the guidance could go out the window. Put differently, they are far more worried about the impact tariffs may have in the broader economy than they are to their business. If consumer demand changes due to a recessionary environment, Fox (along with basically every other company) will need to completely reorient. That said, they’re already moving aggressively to navigate some of this on their side, though to be fair most of this was serendipitous (already planned):
- Doing some offsetting via supply chain adjustments
- Shuttering certain operations as part of a cost cutting initiative (e.g., one Taiwan facility closed, though this, and all other cost cutting, was planned a long time ago)
- Reshoring some production (Gainesville – ramping; this too was previously planned)
If you haven’t followed the company, they have units in automotive, powersports and “specialty” sports. This specialty sports group (SSG) is where their bike lineup lives, which they pair with Marucci, their basesball/softball company (unfortunately. for the purposes of most of my readers…this muddies the benchmarking). Thankfully, plenty of sell side analysts asked pointed questions around the bike unit/industry, and the management team did not balk with any of their replies.
Here is a summarization of my bike specific notes following the call…
- No China exposure: Everything’s coming from Taiwan or made/assembled in the US. Minimal tariff exposure on the manufacturing side.
- Inventory stabilizing: Post-COVID correction appears largely over.
- OEMs steady: No signs of distress, management tone was confident.
- New product launches: High-end fork/shock lines launched in Q1 were well received.
- Marzocchi gaining share: This is their foray into the “entry premium” (lol) category and its working.
Management wasn’t throwing a victory parade, but there was far more optimism than caution. The phrase “the team was smiling” is vague, but interesting, especially compared to prior quarter calls.
Financial Health
Nothing huge to report here or surprises from last quarter. Their CFO continues to talk extensively about deleveraging additional amounts. I believe their aim is to get to something around 3x run rate EBITDA, and they are currently around a 4.5x run rate EBITDA where covenants tighten. They made some headway here, and its expected they make additional headway here, especially on the back half of 2025. The cost savings initiatives they kicked off awhile back are starting to bare fruit, but this too is something that is expected to really accelerate in Q3/Q4.
Worth noting, inventories remain unchanged compared to Q4 2024 levels. However these levels are significantly elevated on a historical basis. For context, the company had inventory of $127M in 2020 (14% of FY 2020 revenue) and closed 2024 at ~$400M of inventory (28% of FY 2024 revenue). To get back to that 14% number, the company needs to cut their inventory number roughly in half. This has not been an area of much interest from the sell side analysts, and Fox did suggest some of this was “getting ahead of tariffs” (which I think is a bit of a fib). The one big upside I can speak to here is the rate of change in the damper game has significantly slowed, so carrying more inventory isn’t as big of a negative as it might have been 10 years ago, when every 12 months saw the launch of a “paradigm shifting product or standard” that might have relgated your current stock to a conex never to see the light of day again (hyperbole, but you get it).
My Takeaway
Fox Factory is doing a really good job, especially against the backdrop of macro uncertainty (thanks, tariffs). They are executing. They have a really good management team that is handling all parts of the business incredibly well, cutting costs, reducing leverage, doubling down on great products/markets and allocating capital appropriately. There is a reason the market reacted positively following the call, and I think there is good reason to believe the business will return to a place where its generating 14-15% EBITDA margin in Q4. While I wouldn’t rush out to buy the stock (actually, I might), I do feel the only thing that can really throw sand into their fork oil (good one huh?) would be whatever ready, fire, aim idea comes out of the Whitehouse next. If things calm down geopolitically, we might see Fox exit 2025 as the stable, durable, and growth oriented company it was for many years leading through COVID. If Washington keeps lobbing policy grenades or if consumer demand cracks, they’ll need to get creative. But for now, they’re handling the moment like pros.
Feel free to reach out with any questions. Post a comment below or email me at Jeff.Brines@gmail.com
Below are my notes from the conf call if anyone is interested…
Incremental insights from the call
- Footprint consolidation: Taiwan site already shut, more rationalization coming to blunt tariff hit and cut fixed cost. Management expects visible SG&A relief starting Q2.
- Cost-out cadence: “Taking medicine in Q1” matches the 170 bp sequential gross-margin lift; they guide most of the $30-35 M annual run-rate savings to land 2H-25.
- Tariffs: $50 M headwind equals about 5 percent of COGS. Countermeasures: insource to Gainesville, reshore Marucci finishing, dual-source away from China. No evidence of pull-forward buying.
- Working capital discipline: Inventory flat QoQ at $409 M despite volume growth. Target is clear-up at least 10 percent, which could free ~$60 M cash and drop net leverage below 4×.
- Demand color
- Bike: channel inventories “normalizing” with OEM partners upbeat. Recovery chatter starts Q3 if sell-through holds.
- PVG: motorcycle rebound masking softness in UTV/ATV.
- Aftermarket: upfitting strong but interest-rate drag on dealers still real.
- Revenue and cost phasing: Management insists both topline and savings are weighted to back half. That leaves Q2 a pivot quarter; miss here and full-year guide ($1.60–2.60 EPS) becomes difficult.
Updated red-flag list
| Issue | Status | CFO view |
|---|---|---|
| Tariff erosion | $50 M unmitigated risk | Lock pricing action by July or offset via 15 percent footprint shift to US/Mexico |
| Leverage | Net debt ≈ $641 M, 4.5× EBITDA | Use WC release plus savings to repay revolver, push < 3× by YE-26 |
| Bike volatility | Still fragile | Keep opex variable, prioritize volume wins where margin is higher |
| Guidance width | $1 spread on EPS | Street likely prices midpoint; any Q2 wobble will compress multiple |
Action plan (consulting CFO)
- 90-day S&OP sprint – cut inventory 12 percent, freeze any opaque safety-stock buffers.
- Tariff task force – quantify every SKU’s landed cost, re-price or shift supply, update by end of June.
- Cost saving scorecard – weekly tracking of plant closures, head-count moves, SG&A run-rate; publish to lenders.
- Capital spend gate – halt discretionary capex until leverage < 3.5×.
- Portfolio review – carve-out model for legacy low-margin UTV shocks; test buyer interest by Q4.
Bottom line
Sequential margin progress plus a realistic WC playbook can get EBITDA margin back to 14-15 percent exiting 2025 even with tariffs. Deliver that and the stock, now at ~11× FY-25 EPS, has room to re-rate into the low 30s. GlobeNewswire